Spario Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Ujjain, Madhya Pradesh, India, established in 2007.
2007 Ujjain, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Spario Drugs Private Limited

Spario Drugs Private Limited, a struck off private limited company, was established on 11 June 2007 in Ujjain, Madhya Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232MP2007PTC019608. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pankaj Maheshwari (Director), Naval Kishore Maheshwari (Director). Its latest AGM occurred on 30 September 2011, with the balance sheet filed on 31 March 2011. It is based at 5, I Floor Milkipura, Ujjain, Madhya Pradesh, 456001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP2007PTC019608

  • Registration Number

    019608

  • Incorporation Date

    11 June 2007

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 8 Months
  • Last Filing with ROC 31 Mar 2011
Company report

Spario Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Spario Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Spario Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Pankaj Maheshwari Director 11 Jun 2007 Current
Naval Kishore Maheshwari Director 11 Jun 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Spario Drugs.

Enhance accessibility to Spario Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Spario Drugs revenue growth over time
Spario Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Spario Drugs?

Unlock access to Spario Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Spario Drugs?

Unlock and access historical data on people associated with Spario Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Spario Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spario Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Spario Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Spario Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Spario Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Gwalior. was completed.

  • Director Appointment

    Pankaj Maheshwari was appointed as a Director was appointed as a Director on 11 Jun 2007 & has been associated with this company since 18 years 8 months . was recorded as a recent event.

  • Director Appointment

    Naval Kishore Maheshwari was appointed as a Director was appointed as a Director on 11 Jun 2007 & has been associated with this company since 18 years 8 months . was recorded as a recent event.

  • Company Incorporation

    The activity Spario Drugs Private Limited was registered on 11 Jun 2007 with Roc Gwalior & aged 18 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Spario Drugs Private Limited?

The CIN of Spario Drugs Private Limited is U24232MP2007PTC019608.

Where is Spario Drugs Private Limited headquartered?

Spario Drugs Private Limited is headquartered at 5, I Floor Milkipura, Ujjain, Madhya Pradesh, 456001.

When was Spario Drugs Private Limited incorporated?

Spario Drugs Private Limited was incorporated on 11 June 2007.

Who are the current directors of Spario Drugs Private Limited?

The current directors of Spario Drugs Private Limited are

What is the primary industry of Spario Drugs Private Limited?

The primary industry of Spario Drugs Private Limited is Chemicals.

Is Spario Drugs Private Limited a listed company?

Spario Drugs Private Limited is unlisted.

What is the capital structure of Spario Drugs Private Limited?

The authorized capital of Spario Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available